BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3293624)

  • 1. Determination of endotoxin levels and their impact on interleukin-1 generation in continuous ambulatory peritoneal dialysis and hemodialysis.
    Pearson FC; Dubczak J; Weary M; Anderson J
    Blood Purif; 1988; 6(3):207-12. PubMed ID: 3293624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and limulus amebocyte lysate methods.
    Tsuchida K; Takemoto Y; Yamagami S; Edney H; Niwa M; Tsuchiya M; Kishimoto T; Shaldon S
    Nephron; 1997; 75(4):438-43. PubMed ID: 9127331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of chemical analyses of hollow-fiber dialyzer extracts.
    Pearson FC; Bohon J; Lee W; Bruszer G; Sagona M; Dawe R; Jakubowski G; Morrison D; Dinarello C
    Artif Organs; 1984 Aug; 8(3):291-8. PubMed ID: 6383298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hollow-fiber dialyzers and their pyrogenicity testing by Limulus amebocyte lysate.
    Henne W; Schulze H; Pelger M; Tretzel J; von Sengbusch G
    Artif Organs; 1984 Aug; 8(3):299-305. PubMed ID: 6477197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The level of endotoxins in hemodialysis water and dialysate].
    Skarupskiene I; Bumblyte IA; Kuzminskis V
    Medicina (Kaunas); 2007; 43 Suppl 1():81-4. PubMed ID: 17551282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin level measurement in hemodialysis biofilm using "the whole blood assay".
    Marion-Ferey K; Leid JG; Bouvier G; Pasmore M; Husson G; Vilagines R
    Artif Organs; 2005 Jun; 29(6):475-81. PubMed ID: 15926985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference in the Limulus amebocyte lysate assay for endotoxin determination in peritoneal dialysis fluids and concentrates for hemodialysis.
    Bohrer D; Hörner R; do Nascimento PC; Adaime M; Pereira ME; Martins AF; Hartz SA
    J Pharm Biomed Anal; 2001 Dec; 26(5-6):811-8. PubMed ID: 11600292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possible role of Limulus-amebocyte-lysate-reactive material in hemodialysis. First-use syndrome.
    Pearson FC
    Blood Purif; 1987; 5(2-3):115-22. PubMed ID: 3620119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endotoxemia in patients on hemodialysis.
    Taniguchi T; Katsushima S; Lee K; Hidaka A; Konishi J; Ideguchi H; Kawaguchi Y
    Nephron; 1990; 56(1):44-9. PubMed ID: 2234248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early diagnosis of gram-negative peritonitis in continuous ambulatory peritoneal dialysis patients with the Lymulus amebocyte lysate assay.
    Peer G; Serban I; Blum M; Cabili S; Iaina A
    Am J Nephrol; 1992; 12(1-2):19-21. PubMed ID: 1415360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study on limulus amebocyte lysate (LAL) reactive material derived from dialyzers.
    Yoshioka T; Ikegami K; Ikemura K; Shiono S; Uenishi M; Sugimoto H; Sugimoto T
    Jpn J Surg; 1989 Jan; 19(1):38-41. PubMed ID: 2733277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plastics, endotoxins, and the Limulus amebocyte lysate test.
    Roslansky PF; Dawson ME; Novitsky TJ
    J Parenter Sci Technol; 1991; 45(2):83-7. PubMed ID: 2051261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin, endotoxin, and tumor necrosis factor in CAPD dialysate.
    Snitkoff G; Bailie GR; Eisele G
    Perit Dial Int; 1995; 15(6):279-80. PubMed ID: 7578513
    [No Abstract]   [Full Text] [Related]  

  • 14. Limulus amebocyte lysate reactivity, complement activation, and patients' symptoms. Comparison of dialyzer membranes.
    Moss AH; Hamrick RM; Shen SH
    ASAIO Trans; 1989; 35(4):812-5. PubMed ID: 2611049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of the endotoxin test for assessing CAPD peritonitis by gram-negative organisms.
    Ishizaki M; Oikawa K; Miyashita E
    Adv Perit Dial; 1996; 12():199-202. PubMed ID: 8865902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the association between increasing membrane pore size and endotoxin permeability using a novel experimental dialysis simulation set-up.
    Schepers E; Glorieux G; Eloot S; Hulko M; Boschetti-de-Fierro A; Beck W; Krause B; Van Biesen W
    BMC Nephrol; 2018 Jan; 19(1):1. PubMed ID: 29304774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The level of endotoxins in hemodialysis water and dialysate in Lithuanian hemodialysis centers.
    Skarupskienė I; Bumblytė IA; Tamošaitis D; Venterienė J; Kuzminskis V
    Medicina (Kaunas); 2010; 46(8):556-60. PubMed ID: 20966633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the inflammatory potential of bioaerosols from a duck-fattening unit by using a limulus amebocyte lysate assay and human whole blood cytokine response.
    Zucker BA; Scharf P; Kersten C
    J Vet Med B Infect Dis Vet Public Health; 2006 May; 53(4):176-80. PubMed ID: 16629985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Endotoxemia in Stable Hemodialysis Patients an Artefact? Limitations of the Limulus Amebocyte Lysate Assay and Role of (1→3)-β-D Glucan.
    Wong J; Zhang Y; Patidar A; Vilar E; Finkelman M; Farrington K
    PLoS One; 2016; 11(10):e0164978. PubMed ID: 27764208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxins and medical devices.
    Ross VC; Twohy CW
    Prog Clin Biol Res; 1985; 189():267-81. PubMed ID: 4048209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.